Success Metrics

Clinical Success Rate
80.0%

Based on 56 completed trials

Completion Rate
80%(56/70)
Active Trials
0(0%)
Results Posted
36%(20 trials)
Terminated
14(17%)

Phase Distribution

Ph phase_1
20
24%
Ph early_phase_1
1
1%
Ph not_applicable
4
5%
Ph phase_2
16
19%

Phase Distribution

21

Early Stage

16

Mid Stage

0

Late Stage

Phase Distribution41 total trials
Early Phase 1First-in-human
1(2.4%)
Phase 1Safety & dosage
20(48.8%)
Phase 2Efficacy & side effects
16(39.0%)
N/ANon-phased studies
4(9.8%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

73.7%

56 of 76 finished

Non-Completion Rate

26.3%

20 ended early

Currently Active

0

trials recruiting

Total Trials

83

all time

Status Distribution
Completed(56)
Terminated(20)
Other(7)

Detailed Status

Completed56
Terminated14
unknown7
Withdrawn6

Development Timeline

Analytics

Development Status

Total Trials
83
Active
0
Success Rate
80.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (2.4%)
Phase 120 (48.8%)
Phase 216 (39.0%)
N/A4 (9.8%)

Trials by Status

unknown78%
withdrawn67%
terminated1417%
completed5667%

Recent Activity

Clinical Trials (83)

Showing 20 of 83 trialsScroll for more
NCT00898508

Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease

Completed
NCT00408590Phase 1

Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Completed
NCT00499083Phase 2

Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)

Completed
NCT00665457Phase 2

Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery

Terminated
NCT00900224

Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia

Unknown
NCT00372736Phase 1

AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors

Completed
NCT00641030Phase 1

Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic Syndromes

Completed
NCT00788307Phase 1

Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to External-Beam Radiation Therapy

Terminated
NCT00436566Phase 2

Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery

Completed
NCT01673217Phase 1

Decitabine, Vaccine Therapy, and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

Completed
NCT00900055

Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma

Completed
NCT00898092

Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia

Unknown
NCT01160705

Biomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2

Completed
NCT01155583Phase 1

Low-Dose Azacitidine, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma

Completed
NCT00389805Phase 1

Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors

Completed
NCT01270880Phase 2

Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy

Completed
NCT00498953Phase 1

Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx

Completed
NCT00646659Phase 2

Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery

Terminated
NCT01105312Phase 1

Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer

Completed
NCT00898261

Gene Expression in Tissue From Patients With Acute Lymphoblastic Leukemia

Completed

Drug Details

Intervention Type
GENETIC
Total Trials
83